We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$7.47B
AUM Growth
+$318M
Cap. Flow
-$240M
Cap. Flow %
-3.22%
Top 10 Hldgs %
15.62%
Holding
988
New
245
Increased
155
Reduced
180
Closed
244

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$145M
2
BKNG icon
Booking.com
BKNG
+$116M
3
EA icon
Electronic Arts
EA
+$87.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$74.1M
5
MSFT icon
Microsoft
MSFT
+$66.5M

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 31.02%
3 Industrials 9.63%
4 Financials 6.43%
5 Consumer Discretionary 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
451
Wave Life Sciences
WVE
$1.19B
$2.45M 0.03%
349,484
-137,730
-28% -$635K
HPQ icon
452
HP
HPQ
$25.8B
$2.42M 0.03%
+90,159
New +$2.5M
AKAM icon
453
Akamai
AKAM
$17.2B
$2.42M 0.03%
28,705
+19,372
+208% +$1.69M
CNK icon
454
Cinemark Holdings
CNK
$4.4B
$2.37M 0.03%
273,378
+22,257
+9% +$251K
OCEA
455
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
$2.34M 0.03%
225,000
ODP
456
DELISTED
ODP
ODP
$2.31M 0.03%
50,706
+16,467
+48% +$703K
ABOS icon
457
Acumen Pharmaceuticals
ABOS
$165M
$2.3M 0.03%
426,172
-5,986
-1% -$40.2K
JUN
458
DELISTED
Juniper II Corp.
JUN
$2.29M 0.03%
225,000
TYRA icon
459
Tyra Biosciences
TYRA
$1.61B
$2.27M 0.03%
299,016
+57,917
+24% +$410K
BNAI
460
Brand Engagement Network
BNAI
$93.5M
$2.27M 0.03%
22,500
BFK
461
DELISTED
BlackRock Municipal Income Trust
BFK
$2.25M 0.03%
+223,732
New +$2.18M
BLE
462
DELISTED
BlackRock Municipal Income Trust II
BLE
$2.24M 0.03%
+216,475
New +$2.19M
SEER icon
463
Seer Inc
SEER
$121M
$2.22M 0.03%
382,754
+40,180
+12% +$271K
MYD
464
DELISTED
BlackRock MuniYield Fund
MYD
$2.13M 0.03%
+205,049
New +$2.09M
AMYT
465
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$2.09M 0.03%
286,543
-1,439
-0.5% -$10.2K
CGEM icon
466
Cullinan Oncology
CGEM
$1.1B
$2.07M 0.03%
+195,839
New +$2.38M
ASBP
467
Aspire Biopharma
ASBP
$9.14M
$2.06M 0.03%
167
EVE
468
DELISTED
EVe Mobility Acquisition Corp
EVE
$2.06M 0.03%
200,000
BFAC
469
DELISTED
Battery Future Acquisition Corp.
BFAC
$2.05M 0.03%
200,000
JGGC
470
DELISTED
Jaguar Global Growth Corporation I Class A Ordinary Shares
JGGC
$2.04M 0.03%
200,000
TVTX icon
471
Travere Therapeutics
TVTX
$5.89B
$2.04M 0.03%
96,908
-171,267
-64% -$3.63M
RAIN
472
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$2.04M 0.03%
254,628
+134,928
+113% +$847K
DEVS
473
DELISTED
DevvStream Corp
DEVS
$2.04M 0.03%
20,000
HMA
474
DELISTED
Heartland Media Acquisition Corp.
HMA
$2.03M 0.03%
200,005
ALCE
475
DELISTED
Alternus Clean Energy Inc
ALCE
$2.02M 0.03%
8,000

Similar funds

Woodline Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Woodline Partners held 988 positions worth $7.47B, up 4.4% from $7.16B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $240M in Q4 2022, closing 244 positions and reducing 180 holdings. Its most notable exit was Amazon, an estimated $77.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in Booking.com worth $123M.

  • Woodline Partners's largest Q4 2022 buy was Booking.com: 1,526,600 shares worth $123M.
  • Woodline Partners added most to TE Connectivity in Q4 2022, an estimated $145M increase.
  • Woodline Partners's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $169M.
  • Woodline Partners fully exited Amazon in Q4 2022, selling an estimated $77.2M.
  • Woodline Partners's ten largest holdings make up 16% of its $7.47B portfolio in Q4 2022.
  • Woodline Partners opened 245 new positions and closed 244 in Q4 2022.
  • Woodline Partners's portfolio value rose 4.4% quarter-over-quarter to $7.47B.

Based on Woodline Partners's 13F filing for Q4 2022, filed 14 Feb 2023.